As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

OncoInv has signed a distribution partnership with MaxBloch Clinical Laboratories to introduce the OncoSeek® multi-cancer ...

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

A new AI tool BMVision speeds up kidney cancer detection, cutting radiology review time by a third and supporting earlier, ...

Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: ...

Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medical On ...

Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning systems are uncovering hidden patterns in cancer data that even veteran ...

The National Institute for Research and Treatment (NICRAT) has trained health workers in Nigeria’s Southwest geopolitical ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that Providence Swedish Cancer Institute and the ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...